PMVP

PMV Pharmaceuticals Inc

May 20 • 04:00PM ET

1.31

0.00 0.00 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NVCT BCAB BDTX CCCC GLUE

| Held by: VTI VXF IWC BTEC AVTM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.48	Insider Own	8.32%	Shs Outstand	53.33M	Perf Week	1.55%
Market Cap	69.86M	Forward P/E	-	EPS next Y	-1.12	Insider Trans	0.00%	Shs Float	48.90M	Perf Month	-10.27%
Enterprise Value	-23.40M	PEG	-	EPS next Q	-0.40	Inst Own	64.41%	Short Float	5.39%	Perf Quarter	23.58%
Income	-78.34M	P/S	-	EPS this Y	1.13%	Inst Trans	-7.29%	Short Ratio	3.80	Perf Half Y	-7.75%
Sales	0.00M	P/B	0.79	EPS next Y	23.69%	ROA	-58.65%	Short Interest	2.63M	Perf YTD	4.80%
Book/sh	1.65	P/C	0.75	EPS next 5Y	17.70%	ROE	-63.16%	52W High	1.88 -30.32%	Perf Year	40.74%
Cash/sh	1.75	P/FCF	-	EPS past 3/5Y	2.74% -13.98%	ROIC	-89.06%	52W Low	0.85 54.12%	Perf 3Y	-76.81%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.94% 5.01%	Perf 5Y	-96.33%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-26.14%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.38	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	11.14	EPS Q/Q	-0.77%	SMA20	-4.87%	Beta	1.41	Target Price	4.33
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-6.03%	Rel Volume	0.13	Prev Close	1.31
Employees	54	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-2.27%	Avg Volume	693.53K	Price	1.31
IPO	Sep 25, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% -	Trades		Volume	87,722	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)